DexCom Inc (XTER:DC4)
€ 78.11 5.59 (7.71%) Market Cap: 29.79 Bil Enterprise Value: 29.88 Bil PE Ratio: 47.63 PB Ratio: 15.70 GF Score: 73/100

Dexcom Inc at William Blair Growth Stock Conference Transcript

Jun 07, 2023 / 05:40PM GMT
Release Date Price: €114.42 (-2.09%)
Malgorzata Maria Kaczor Andrew
William Blair & Company L.L.C., Research Division - Partner & Research Analyst

Good afternoon, everyone. My name is Margaret Kaczor. I am the research analyst at William Blair & Company who covers Dexcom. Thank you guys for all being here. Obviously, we got 2 small rooms, so we will work on that next year.

I am required to inform you that I personally own shares of Dexcom. And beyond that, you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com.

With that said, pleased to introduce Jereme Sylvain, CFO of Dexcom.

Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO

Thanks, Margaret. And thanks, everyone, for being here. Certainly excited to be back another year at the conference, a wonderful conference and a pleasure to be in front of everybody again. We want to just take a little bit of time, run through the organization, run through a little bit of background, leave a little bit of time potentially for Q&A, but really talk about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot